Polyrizon Ltd. (PLRZ)
NASDAQ: PLRZ · Real-Time Price · USD
12.70
+0.18 (1.40%)
Jul 1, 2026, 12:21 PM EDT - Market open
Polyrizon Market Cap
Polyrizon has a market cap or net worth of $23.76 million as of July 1, 2026. Its market cap has increased by 434.10% in one year.
Market Cap
23.76M
Enterprise Value
11.16M
1-Year Change
434.10%
Ranking
Category
Stock Price
$12.70
Market Cap Chart
Since the IPO on October 29, 2024, Polyrizon's market cap has increased from $6.50M to $23.76M, an increase of 265.55%. That is a compound annual growth rate of 117.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 23.76M | 75.60% |
| Dec 31, 2025 | 13.53M | 48.69% |
| Dec 31, 2024 | 9.10M | 40.00% |
| Oct 29, 2024 | 6.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Skye Bioscience | 23.89M |
| Longeveron | 22.29M |
| Marker Therapeutics | 21.93M |
| Pluri | 21.92M |
| VYNE Therapeutics | 21.62M |
| Allarity Therapeutics | 20.68M |
| Lipocine | 20.28M |
| Cellectar Biosciences | 20.14M |